Price Vision Group Becomes First in Indiana to Treat Degenerative Corneal Disease, Neurotrophic Keratitis, with New FDA-Approved Drug
Indianapolis, IN – Dr. Matthew Feng of Price Vision Group will be the first ophthalmologist in Indiana to use the new FDA-approved drug, Oxervate™ (cenegermin). The patient, Tina Hunter, has vision loss due to neurotrophic keratitis (NK). NK is a rare, degenerative corneal disease for which previous treatments include artificial tears or autologous serum tears, which are customLeer Más
Read More
STAAR Surgical Partners With Price Vision Group for EVO USA Study
Join the EVO USA Study Break free from Glasses & Contact Lenses Ready to Experience Visual Freedom? If you suffer from nearsightedness or astigmatism, EVO may improve your distance vision without glasses or contact lenses. Your eyeglass prescription can usually tell you how much nearsightedness and/or astigmatism you have. Consult with your eye doctor, whoLeer Más
Read More
Price Vision Group Participating in Clinical Study of Investigational Growth Factor Treatment for Eye Disorder, Fuchs Endothelial Corneal Dystrophy
Indianapolis, IN – March 10, 2021 – Price Vision Group announced today that it is the first site to initiate patient treatment in a clinical trial evaluating use an experimental drug treatment in conjunction with a surgical procedure that treats the back surface of the cornea to restore vision in patients with a condition calledLeer Más
Read More
Price Vision Group enrolling LASIK clinical study participants
LASIK,Price Vision Group,Uncategorized
Price Vision Group is currently enrolling participants for a LASIK clinical study. If you are nearsighted and need glasses/contacts to see clearly, you may qualify for this study. Qualified study participants will be compensated for their time. There is no cost to the patient but the clinical study will require participants to attend several postoperative…
Read More
Trefoil Therapeutics Partners With Price Vision Group for Patients with Corneal Endothelial Dystrophies
Cornea Transplantation,Price Vision Group
Trefoil Therapeutics Begins First Clinical Trial at Price Vision Group for Patients with Corneal Endothelial Dystrophies SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics today announced it has initiated the first clinical trial of its engineered Fibroblast Growth Factor-1 TTHX1114 for the treatment of people with corneal endothelial dystrophies (CED), including Fuchs Endothelial Corneal Dystrophy. T
Read More
Price Vision Group Frontline Hero Contest Winner Undergoes LASIK Eye Surgery
Indianapolis, Indiana – Back in May, Price Vision Group started a promotion to thank the hardworking essential heroes by giving four lucky winners free LASIK eye surgery. Hospital worker, Carolyn Rogers was the first contest winner to undergo the procedure on Tuesday. “The idea came up during a staff meeting for the refractive department. We wereLeer Más
Read More
Our response to COVID-19
In the following video, Dr. Price gives an update on Price Vision Group and outlines the steps we’re taking to keep our patients and staff safe while maintaining the care of our patients. Some highlights of the message: Non-emergency surgeries will be postponed Follow-up appointments will be kept if the doctor determines that the patientLeer Más
Read More
Price Vision Group Celebrates 25 Years of LASIK
Price Vision Group Celebrates 25 Years of LASIK, the first in the state of Indiana. January 2020 marks the 25-year anniversary of Price Vision Group providing LASIK eye surgery. We continue to see happy patients from those early years when Dr. Price performed LASIK as part of an investigational study. From the start, we wereLeer Más
Read More
Descemet’s Stripping Only… a substitute for DMEK? An update to a previous post
Cornea Transplantation,Price Vision Group
This is an update to a post published on 9/25/17. You can find the original post here. Descemet’s Stripping Only…a substitute for DMEK? By Francis W. Price, Jr., MD & Matthew T. Feng, MD We are always looking for better ways to correct the visual difficulties of patients with Fuchs’ dystrophy. In fact, that isLeer Más
Read More
Dr. Francis W. Price, Jr. to Receive Thomas C. Hasbrook Award
INDIANAPOLIS—Bosma Enterprises, an Indianapolis-based nonprofit organization dedicated to creating opportunities for Hoosiers who are blind or visually impaired, is set to honor two prominent supporters at its annual Hasbrook Awards Luncheon. The event will be held Nov. 2 at The Crane Bay, 551 W. Merrill St., Indianapolis, to raise funds for employment and training programs.Leer Más
Read More